DIMERIX LIMITED — Investor Relations & Filings
Filings indexed
1,124
across all filing types
Latest filing
2009-03-24
Regulatory Filings
Country
AU
Australia
Listing
ASX
DXB
Dimerix Limited focuses on the development of therapeutic treatments for inflammatory diseases, with a primary emphasis on kidney and respiratory conditions. The company utilizes its proprietary Receptor-Heteromer Investigation Technology (DMX-Technology) to identify and validate G protein-coupled receptor (GPCR) targets. Its lead candidate, DMX-200, is a chemokine receptor (CCR2) antagonist currently in Phase 3 clinical trials for the treatment of Focal Segmental Glomerulosclerosis (FSGS). The company is also advancing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) and exploring applications for diabetic kidney disease. The core strategy involves targeting multiple signaling pathways simultaneously to address unmet medical needs in chronic inflammatory and fibrotic diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Top 20 Shareholders 1 page ?Kb | 2009-03-24 | English | |
| Top 20 Optionholders 1 page ?Kb | 2009-03-24 | English | |
| MPS Field Trials 1 page ?Kb | 2009-03-12 | English | |
| Half Yearly Report and Accounts 19 pages ?Kb | 2009-02-26 | English | |
| Top 20 Shareholders 1 page ?Kb | 2009-02-23 | English | |
| Top 20 Optionholders 1 page ?Kb | 2009-02-23 | English |
Browse filings by year
24 years- 2026 14 filings
- 2024 113 filings
- 2023 91 filings
- 2022 40 filings
- 2021 70 filings
- 2020 56 filings
- 2019 41 filings
- 2018 55 filings
- 2017 78 filings
- 2016 52 filings
- 2015 3 filings
- 2014 34 filings
- 2013 41 filings
- 2012 28 filings
- 2011 15 filings
- 2010 45 filings
- 2009 66 filings
- 2008 81 filings
- 2007 4 filings
- 2006 63 filings
- 2005 63 filings
- 2004 36 filings
- 2003 31 filings
- 2002 4 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2009
15 filings
| |||||
| 39729375 | Top 20 Shareholders 1 page ?Kb | 2009-03-24 | English | ||
| 39729367 | Top 20 Optionholders 1 page ?Kb | 2009-03-24 | English | ||
| 39729378 | MPS Field Trials 1 page ?Kb | 2009-03-12 | English | ||
| 39729385 | Half Yearly Report and Accounts 19 pages ?Kb | 2009-02-26 | English | ||
| 39729399 | Top 20 Shareholders 1 page ?Kb | 2009-02-23 | English | ||
| 39729391 | Top 20 Optionholders 1 page ?Kb | 2009-02-23 | English | ||
| 39729429 | Top 20 Shareholders 1 page ?Kb | 2009-01-29 | English | ||
| 39729425 | Top 20 Optionholders 1 page ?Kb | 2009-01-29 | English | ||
| 39729415 | Investor Update 4 pages ?Kb | 2009-01-29 | English | ||
| 39729403 | Appendix 4C - quarterly 5 pages ?Kb | 2009-01-29 | English | ||
| 39729435 | Expiry of Options 1 page ?Kb | 2009-01-28 | English | ||
| 39729441 | Change of Director`s Interest Notice 3 pages ?Kb | 2009-01-20 | English | ||
| 39729463 | Appendix 3B 9 pages ?Kb | 2009-01-05 | English | ||
| 39729453 | Top 20 Shareholders 1 page ?Kb | 2009-01-05 | English | ||
| 39729450 | Top 20 Optionholders 1 page ?Kb | 2009-01-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
DIMERIX LIMITED via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/64804/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=64804 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=64804 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=64804 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 64804}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for DIMERIX LIMITED (id: 64804)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.